GLP-1 receptor agonists trace their roots back to exendin-4, a peptide isolated from Gila monster venom in the early 1990san insight that eventually led to exenatide and reshaped the treatment of diabetes and metabolic disease
Trimethylamine/Trimethylamine-N-Oxide as a key between diet and cardiovascular diseases
In epidemiological research, those who consume diets rich in lycopene, an antioxidant that gives fruits and vegetables like tomatoes, pink grapefruit and watermelon their red pigment, has been linked to a reduced risk of prostate cancer, though evidence is mixed
GLP-1 medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Such results position retatrutide as a potential game-changer, offering hope for a more effective approach to combating obesity
Medicine is rapidly moving from what works statistically to what works biologically for this individual, and posts like this highlight just how much hidden variability exists beneath standard treatment protocols